"Matrix produkuj\u00EDc\u00ED karcinom prsu s myoepiteli\u00E1ln\u00ED diferenciac\u00ED-popis 11 p\u0159\u00EDpad\u016F a p\u0159ehled literatury se zam\u011B\u0159en\u00EDm na histogenezi a diferenci\u00E1ln\u00ED diagnostiku" . . . . "5"^^ . "8"^^ . . "3" . . "\u010Cesk\u00E1 gynekologie" . . . "[38A1E4EB1BF6]" . "Kajo, K." . "RIV/00216208:11120/04:00001444" . "Ry\u0161ka, A." . "Matrix-Producng Breast Carcinoma with Myoepithelial Differentiation - Description of 11 Cases and Review of Literature Aimed at Histogenesis and Differential Diagnosis"@en . "C\u00EDlem pr\u00E1ce je prezentovat variabiln\u00ED morfologii vz\u00E1cn\u00E9 varianty metaplastick\u00E9ho karcinomu prsu ? tzv. matrix-produkuj\u00EDc\u00EDho karcinomu a imunohistochemicky zjistit m\u00EDru myoepiteli\u00E1ln\u00ED diferenciace. Posoudit biologick\u00E9 chov\u00E1n\u00ED l\u00E9ze. Typ studie: P\u0159ehled klinicko-patologick\u00FDch parametr\u016F u 11 p\u0159\u00EDpad\u016F. N\u00E1zev a s\u00EDdlo pracovi\u0161t\u011B: Bioptick\u00E1 laborato\u0159, s.r.o., Plze\u0148, a \u0160ikl\u016Fv \u00FAstav patologie LF UK a FN, Plze\u0148. Metodika: Zahrnuto celkem 11 p\u0159\u00EDpad\u016F z mam\u00E1rn\u00EDho registru Bioptick\u00E9 laborato\u0159e s.r.o. v Plzni, \u00FAstav\u016F patologie LF v Hradci Kr\u00E1lov\u00E9 a Martin\u011B a Bioptick\u00E9 laborato\u0159e v Ho\u0159ovic\u00EDch. Analyzov\u00E1ny byly: morfologie, stage, grade a dal\u0161\u00ED sledov\u00E1n\u00ED nemocn\u00FDch. Myoepiteli\u00E1ln\u00ED fenotyp se stanovil imunohistochemicky pomoc\u00ED detek\u010Dn\u00EDho syst\u00E9mu LSAB+ (Dako) a sedmi b\u011B\u017En\u00FDch myoepiteli\u00E1ln\u00EDch marker\u016F ? GFAP, aktin S, kalponin, cytokeratin 14, p63, CD10 a P-cadherin. Zji\u0161\u0165ov\u00E1na byla t\u00E9\u017E exprese onkogen\u016F p53 a Her2/neu. V\u00FDsledky: Jedn\u00E1 se o m\u00E9n\u011B obvyklou variantu bif\u00E1zick\u00E9ho, metaplastick\u00E9ho karcinomu, kde struktury vysoce ma" . "1"^^ . . "Kinkor, Z." . "Matrix produkuj\u00EDc\u00ED karcinom prsu s myoepiteli\u00E1ln\u00ED diferenciac\u00ED-popis 11 p\u0159\u00EDpad\u016F a p\u0159ehled literatury se zam\u011B\u0159en\u00EDm na histogenezi a diferenci\u00E1ln\u00ED diagnostiku" . "Presentation of variable morphology of the so-called matrix-producing carcinoma, the rare variant of metaplastic breast carcinoma. Establish the extent of myoepithelial phenotype by immunohistochemistry and assess behaviour of the lesion. Design: Review of clinicopathologic data of 11 cases. Setting: Private Biopsy Lab s.r.o., Pilsen and \u0160ikl?s Department of Pathology, Charles University and Faculty Hospital, Pilsen. Methods: Included are eleven cases from Breast Registry, Biopsy Lab s.r.o., Pilsen and Pathology Department, Faculty Hospital in Hradec Kr\u00E1lov\u00E9 and Martin and from Biopsy Lab in Ho\u0159ovice. Analyzed were morphology, stage, grade and follow up. Myoepithelial phenotype was demonstrated immunohistochemically by LSAB+ system (DAKO) and seven conventional myoepithelial markers (GFAP, aktin S, calponin, cytokeratin 14, p63, CD10 and P-cadherin) were used. Oncogene p53 and Her2/neu were also detected. Results: Matrix-producing carcinoma is an extremely rare type of metaplastic carcinoma of the bre"@en . . "breast; metaplastic carcinoma; matrix-producing carcinoma; sarcomatoid carcinoma; heterologous; myoepithelial differentiation"@en . . "S" . "69" . "\u0160vec, Alexandr" . . . . "11120" . . . "CZ - \u010Cesk\u00E1 republika" . "Matrix-Producng Breast Carcinoma with Myoepithelial Differentiation - Description of 11 Cases and Review of Literature Aimed at Histogenesis and Differential Diagnosis"@en . . "Matrix produkuj\u00EDc\u00ED karcinom prsu s myoepiteli\u00E1ln\u00ED diferenciac\u00ED-popis 11 p\u0159\u00EDpad\u016F a p\u0159ehled literatury se zam\u011B\u0159en\u00EDm na histogenezi a diferenci\u00E1ln\u00ED diagnostiku"@cs . "C\u00EDlem pr\u00E1ce je prezentovat variabiln\u00ED morfologii vz\u00E1cn\u00E9 varianty metaplastick\u00E9ho karcinomu prsu ? tzv. matrix-produkuj\u00EDc\u00EDho karcinomu a imunohistochemicky zjistit m\u00EDru myoepiteli\u00E1ln\u00ED diferenciace. Posoudit biologick\u00E9 chov\u00E1n\u00ED l\u00E9ze. Typ studie: P\u0159ehled klinicko-patologick\u00FDch parametr\u016F u 11 p\u0159\u00EDpad\u016F. N\u00E1zev a s\u00EDdlo pracovi\u0161t\u011B: Bioptick\u00E1 laborato\u0159, s.r.o., Plze\u0148, a \u0160ikl\u016Fv \u00FAstav patologie LF UK a FN, Plze\u0148. Metodika: Zahrnuto celkem 11 p\u0159\u00EDpad\u016F z mam\u00E1rn\u00EDho registru Bioptick\u00E9 laborato\u0159e s.r.o. v Plzni, \u00FAstav\u016F patologie LF v Hradci Kr\u00E1lov\u00E9 a Martin\u011B a Bioptick\u00E9 laborato\u0159e v Ho\u0159ovic\u00EDch. Analyzov\u00E1ny byly: morfologie, stage, grade a dal\u0161\u00ED sledov\u00E1n\u00ED nemocn\u00FDch. Myoepiteli\u00E1ln\u00ED fenotyp se stanovil imunohistochemicky pomoc\u00ED detek\u010Dn\u00EDho syst\u00E9mu LSAB+ (Dako) a sedmi b\u011B\u017En\u00FDch myoepiteli\u00E1ln\u00EDch marker\u016F ? GFAP, aktin S, kalponin, cytokeratin 14, p63, CD10 a P-cadherin. Zji\u0161\u0165ov\u00E1na byla t\u00E9\u017E exprese onkogen\u016F p53 a Her2/neu. V\u00FDsledky: Jedn\u00E1 se o m\u00E9n\u011B obvyklou variantu bif\u00E1zick\u00E9ho, metaplastick\u00E9ho karcinomu, kde struktury vysoce ma"@cs . "Matrix produkuj\u00EDc\u00ED karcinom prsu s myoepiteli\u00E1ln\u00ED diferenciac\u00ED-popis 11 p\u0159\u00EDpad\u016F a p\u0159ehled literatury se zam\u011B\u0159en\u00EDm na histogenezi a diferenci\u00E1ln\u00ED diagnostiku"@cs . "Boudov\u00E1, L." . "572541" . "RIV/00216208:11120/04:00001444!RIV09-MSM-11120___" . "1210-7832" . .